Liver disorder and drugs of ingredients of trastuzumab (a real world drug study)
Summary:
Liver disorder is found among people who take drugs with ingredients of trastuzumab, especially for people who are female, 60+ old , have been taking the drugs for < 1 month. This phase IV clinical study is created by eHealthMe based on reports of 73,720 people who have side effects when taking drugs with ingredients of trastuzumab from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Herceptin.
73,720 people reported to have side effects when taking drugs with ingredients of trastuzumab.
Among them, 212 people (0.29%) have Liver disorder
What is Liver disorder?
Liver disorder (liver diseases) is found to be associated with 1,734 drugs and 2,047 conditions by eHealthMe. Check the latest studies of Liver disorder.
Number of reports submitted per year:
Time on drugs with ingredients of trastuzumab when people have Liver disorder *:
- < 1 month: 30.23 %
- 1 - 6 months: 23.26 %
- 6 - 12 months: 13.95 %
- 1 - 2 years: 30.23 %
- 2 - 5 years: 2.33 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Liver disorder when taking drugs with ingredients of trastuzumab *:
- female: 95 %
- male: 5 %
Age of people who have Liver disorder when taking drugs with ingredients of trastuzumab *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.66 %
- 30-39: 7.89 %
- 40-49: 16.45 %
- 50-59: 28.95 %
- 60+: 46.05 %
Conditions people have *:
You may use this to check any potential undetected conditions.
Other drugs people take *:
You may use this to check any potential interacting drugs.
Other side effects people have besides Liver disorder *:
You may use this to check any potential undetected side effects.
* Approximation only. Some reports may have incomplete information.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Saleh M, Bourcier T, Noel G, Speeg-Schatz C, Gaucher D, "Bilateral macular ischemia and severe visual loss following trastuzumab therapy", Acta Oncologica, 2011 Apr .
- Saleh M, Bourcier T, Noel G, Speeg-Schatz C, Gaucher D, "Bilateral macular ischemia and severe visual loss following trastuzumab therapy", Acta Oncologica, 2011 Apr .
Related studies
Drugs with ingredients of trastuzumab, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on trastuzumab. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Dymista and Effexor Xr - 4 seconds ago
- Could Amlodipine cause Paranasal Sinus Hypersecretion? - 21 seconds ago
- Could Albuterol cause Nervousness? - 21 seconds ago
- Drug interactions of Doxepin Hydrochloride and Reglan - 46 seconds ago
- Cyclophosphamide and Hallucinations for Women aged 60+ - 48 seconds ago
- Cyclophosphamide and Hallucination for Women aged 60+ - 48 seconds ago
- Cyclophosphamide and Sensory Hallucinations for Women aged 60+ - 49 seconds ago
- Breathing Sounds - Abnormal (Stridor) and drugs of ingredients of gentamicin sulfate - 49 seconds ago
- Tylenol W/ Codeine and Inflammation - Bronchi for Women aged 50-59 - a minute ago
- Tylenol W/ Codeine and Bronchitis for Women aged 50-59 - a minute ago